FBIOP - Fortress Biotech Inc


6.8
0   0%

Share volume: 0
Last Updated: 01-03-2025

PREVIOUS CLOSE
CHG
CHG%

$6.80
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Company vs Stock growth
vs
Performance
5 Days
-3.37%
1 Month
0.07%
3 Months
34.10%
6 Months
-3.37%
1 Year
-46.21%
2 Year
-64.33%
Key data
Stock price
$6.80
P/E Ratio 
0.00
DAY RANGE
$5.46 - $6.58
EPS 
$0.00
52 WEEK RANGE
$5.10 - $18.00
52 WEEK CHANGE
-$48.12
MARKET CAP 
37.918 M
YIELD 
N/A
SHARES OUTSTANDING 
3.427 M
DIVIDEND
$0.1953
EX-DIVIDEND DATE
06-14-2024
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$7,435
AVERAGE 30 VOLUME 
$11,670
Company detail
CEO: Lindsay Rosenwald
Region: US
Website: http://www.fortressbiotech.com
Employees: 38
IPO year: -
Issue type:
Market: XNAS
Industry:
Sector:

fortress biotech, inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. fortress plans to develop and commercialize products that it acquires both directly as well as indirectly by establishing subsidiary companies, also known as fortress companies. the company will leverage its biopharmaceutical business expertise and drug development capabilities to help the fortress companies achieve their goals. additionally, the company will provide funding and management services to each of the fortress companies and from time to time the company and the fortress companies will seek licensing, partnerships, joint ventures, and/or public and private financings to accelerate and provide additional funding to support their research and development programs.

Recent news